The University of Utah

The University of Utah

The University of Utah

Date Founded



101 Wasatch Dr Rm 215, Salt Lake City, UT, 84112, US

Charitable Causes

Higher Education & Universities
Education Research & Support

Company Description

The University of Utah is a public coeducational space-grant research university in Salt Lake City, Utah, United States. As the state's flagship university, the university offers more than 100 undergraduate majors and more than 92 graduate degree programs. Graduate studies include the S.J. Quinney College of Law and the School of Medicine.The university was established in 1850 as the University of Deseret by the General Assembly of the provisional State of Deseret, making it Utah's oldest institution of higher education.It received its current name in 1892, four years before Utah attained statehood, and moved to its current location in 1900.

Contact Data
Trying to get in touch with decision makers at The University of Utah? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


General Counsel & Vice President

Chief Safety Officer

Chief Philanthropy Officer

Vice President for Student Affairs



Associate Chief Global Officer & Executive Director for Learning Abroad

Board of Trustees

Former Professional at Kennecott Copper Corp.

Co-Founder at Sorenson Impact Foundation

Founder at Price Realty Group

Former Assistant Head of School at Rowland Hall - St. Mark's School

Former Vice President at Merrill Lynch & Co.

President, Board of Directors at George S. and Dolores Dore Eccles Foundation

Of Counsel at Ray Quinney & Nebeker PC

Assistant Professor-David Eccles School of Business at The University of Utah

Chief Executive Officer at Gardner Company

Distinguished Alumni
Harris H. Simmons is now Chairman & Chief Executive Officer at Zions Bancorporation, NA
John E. Warnock is now Co-Founder at Adobe, Inc.
Steven R. Rodgers is now Executive Vice President & General Counsel, Growth Acceleration Team at Intel Corp.
Paths to The University of Utah
Potential Connections via
Relationship Science
The University of Utah

Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs. We are worldwide leaders in the development of a proprietary technology platform that enables specific regulation of gene expression and gene modification. The basis of this platform is a naturally occurring class of transcription factors, zinc finger DNA-binding proteins (ZFPs) which we can engineer to drive desired therapeutic outcomes. Engineered ZFPs can be linked to functional domains that normally activate or repress gene expression to create ZFP transcription factors (ZFP TFs) capable of turning genes on or off. We can also link ZFPs to nuclease domains to create zinc finger nucleases (ZFNs) which enable precise gene-editing in cells. Engineered ZFNs can modify a cell's DNA at a precise location, thereby facilitating correction or disruption of a specific gene or the targeted addition of a new DNA sequence. Sangamo was founded in 1995, went public in 2000, and trades on the Nasdaq Global Market (SGMO). We are located in Richmond, California, in the Bay Area, the birthplace of biotechnology. We are intimately involved in our community through partnerships with academic institutions, relationships with non-profit organizations and ties to advocacy organizations aligned with improving the quality of life for patients with unmet medical needs within our strategic vision.

Sumitomo Dainippon Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.

Non-Profit Donations & Grants
$500K - $1M
$10K - $50K
Non-Profit Donations & Grants Received
Political Donations
ORBIT/FR, Inc. Other Business & Consulting Services | Horsham, PA

ORBIT/FR, Inc. engages in the development, market, and support of automated microwave test and measurement systems for the aerospace and defense, wireless communications, satellite, and automotive industries. Its products include software, radar cross section components, compact range components, near-field scanners, anechoic chambers, positioning equipment, antennas, radio frequency absorbers, acquisition control hardware. The company was founded in 1980 and is headquartered in Horsham, PA.

NV5 Global, Inc. Commercial Scientific Research | Hollywood, FL

NV5 Global, Inc. engages in the provision of professional and technical consulting and certification solutions for public and private sector. It operates through the Infrastructure (INF), and Building, Technology, and Sciences (BTS) segment. The INF segment covers engineering, civil program management, and construction quality assurance practices. The BTS segment includes energy, environmental and building program management practices. The company was founded on September 12, 2011 and is headquartered in Hollywood, FL.

Jaggaer LLC Pension Funds & Sovereign Wealth | Morrisville, NC

Jaggaer LLC provides cloud-based business automation solutions for spend management. It offers spend analysis, savings management, sourcing, supplier management, accounts payable, contract lifecycle management, and inventory management solutions. The company was founded in 1995 and is headquartered in Morrisville, NC.

Awards & Honors
Rank #115
The Chronicle of Philanthropy - Philanthropy 400
Rank #189
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by The University of Utah. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of The University of Utah's profile does not indicate a business or promotional relationship of any kind between RelSci and The University of Utah.